EconoTimes10m
GSK and Pfizer Drop RSV Vaccine Patent Lawsuit
GlaxoSmithKline (NYSE:GSK) and Pfizer (NYSE:PFE) have agreed to dismiss a U.S. patent lawsuit over Pfizers RSV vaccine, ...
GSK resolves patent lawsuit against Pfizer over RSV vaccines
(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's ...
US FDA declines to approve Aldeyra's eye disease drug
The U.S. Food and Drug Administration has declined to approve Aldeyra Therapeutics' treatment for dry eye disease, the ...
Italy to ask immediate suspension of EU Green deal rules following U.S. tariffs
Italy's Industry Minister Adolfo Urso on Thursday told parliament that Rome would ask the European Union to immediately ...
Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna
However, Pfizer and Moderna's revenue and earnings dropped significantly once the pandemic receded, as did their share prices ...